Ingenol mebutate Unknown Status Phase N/A Trials for Actinic Keratosis (AK)

IndicationsStatusPurposePhase
Unknown StatusNot AvailableNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT02090465Assessment of Treatment Success and Quality of Life in Patients With Actinic Keratoses Under Therapy With Ingenol Mebutate in a Period of 8 Weeks